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Summary
The primitive blood circulation requires intravascular
plasma flow [1]. However, it remains unclear whether the
onset of earliest blood circulation is dependent solely on
establishment of a functional circulatory organ or whether
it also requires active processes inherent in blood cells. In
this study, we present novel mechanisms for the onset of
blood circulation by monitoring fluorescently labeled blood
precursors and blood vessels in zebrafish. The earliest
blood circulation occurs synchronously. This synchrony is
achieved by the retention of erythroid precursors on the
lumen of the vasculature after their invasion from the sub-
aortic region, and then by simultaneous release of these
precursors into the flow. Morphological and biochemical
analyses suggest that the onset of blood circulation accom-
panies disruption of blood cell-to-vessel adhesion and
requires metalloprotease-dependent processes. ADAM8,
a member of the a disintegrin and metalloprotease (ADAM)
family, mediates the onset of blood circulation. In ADAM8-
depleted embryos, erythroid cells fail to detach from the
vascular lumen and stagnate. Expression of a protease-
defective ADAM8 in erythroid cells causes dominant-nega-
tive effects on blood circulation, suggesting cell-autono-
mous roles of ADAM8. Based on these findings, we propose
that the first erythroid cells require both flow-dependent
passive and proteolysis-dependent active processes to
enter the circulation.
Results and Discussion
The Onset of Blood Circulation Occurs Synchronously
We visualized the onset of blood circulation in a double-trans-
genic zebrafish line, Tg(fli1a:eGFP)y1 Tg(gata1:mRFP)ko5, in
which blood vessels and erythroid precursors were labeled
with enhanced green fluorescent protein [2] and monomeric*Correspondence: asehara@frontier.kyoto-u.ac.jpred fluorescent protein [3, 4], respectively (Figure 1). The
earliest erythroid precursors, generated in the intermediate
cell mass (ICM) [5–7], were clustered in the ventral region
of the dorsal aorta (DA) at 20–22 hours postfertilization
(hpf). They gradually segregated into two compartments by
w24 hpf, resulting in a major compartment in the subaortic
region and a minor one in the luminal phase of the posterior
cardinal vein (PCV) (Figure 1B). When vessel formation was
significantly advanced at 25–26 hpf, the erythroid cells were
clearly observed migrating from the subaortic region both
into the PCV, as reported previously [8], and into the DA (Fig-
ures 1C and 1D; see also Figures S1A and S1B, Movie S1,
and Movie S2 available online). These live images suggest
that the erythroid cells migrate into the lumen of the vascula-
ture through transendothelial migration, although further
studies are necessary to clarify whether the erythroid cells
invade into the vasculature in a manner similar to transmigra-
tion of mammalian leukocytes. Intravascular blood cells
remained stagnant after invasion into the vasculature despite
the initiation of a heartbeat. Then, when most subaortic blood
precursors had completed the invasion, those in the DA
started to move slowly in a posterior direction before all being
released into the flow virtually simultaneously (Figure 1C;
Movie S1). Thus, the onset of primitive blood circulation is
strictly controlled.
We were particularly interested in the mechanisms control-
ling the release of erythroblasts into the plasma flow after their
slight pause in the lumen of the vessels. Because a significant
proportion of erythroblasts probably attach to endothelial cells
after invasion into the vasculature, especially in the DA lumen,
we next investigated whether the onset of blood circulation
was accompanied by changes in blood cell-to-vessel adhe-
sion. High-power imaging of erythroid cells revealed that
most were attached to the lumen of blood vessels via tiny
membrane protrusions after invasion (Figure S1B). Contact
of the erythroid cells with the vessel lumen during and after
the invasion into the vasculature was further confirmed by
electron microscopy (Figures 1E–1E00; Figure S1C). Membrane
protrusions observed in erythroid cells in live imaging and
electron micrographs suggested the involvement of integrin-
mediated focal adhesion between erythroid cells and the
vasculature. Indeed, the focal adhesion protein vinculin was
localized strongly at the blood-vessel interface in the subaortic
region and only weakly in the lumen of vessels before the onset
of blood circulation (Figure 1F). The vinculin signal decreased
dramatically overall after the initiation of blood circulation,
implying that the onset of blood circulation is associated
with an abrogation of blood cell-to-vessel adhesion.
The Onset of Blood Circulation Requires
Intravascular Metalloproteases
Next, we asked whether this abrogation of blood-vessel adhe-
sion at the onset of blood circulation is caused by metallopro-
tease-dependent degradation of cell adhesion molecules that
mediate attachment of erythroid cells to the vessels. We there-
fore examined the effects of a metal chelator (1,10-orthophe-
nanthroline) [9] and a metalloprotease inhibitor (GM6001)
on the onset of blood circulation. GM6001 is a classical
Figure 1. Onset of Primitive Blood Circulation Occurs
Synchronously
(A) Blood circulation was monitored in live Tg(fli1a:eGFP)y1
Tg(gata1:mRFP)ko5 embryos. The region of imaging is
indicated.
(B) Confocal images of gata1:mRFP+ erythrocytes before (20
and 24 hours postfertilization [hpf]) and after the onset of
circulation (30 hpf). Note that few erythrocytes are found in
the luminal phase of the dorsal aorta (DA) at 24 hpf. Scale
bars represent 25 mm.
(C) Time-lapse imaging capturing the initiation of blood
circulation. Representative live-imaging stills from a key
moment when primitive blood starts to flow in an embryo
are shown. Once vessel formation has proceeded signifi-
cantly at around 26 hpf (0 min), gata1:mRFP+ cells in the sub-
aortic region (double-headed white arrow) become promi-
nently motile and begin invasion into the DA and posterior
cardinal vein (PCV) one after another. The sequential blood
invasion into the DA (72 min) is followed by the sudden onset
of circulation in the DA (74 min). Finally, the vast majority
of RFP+ cells in the vasculature start to flow all at once
(76 min). Scale bars represent 25 mm.
(D) Invasion of gata1:mRFP+ cells (colored dots) into the
vasculature. Scale bar represents 25 mm.
(E–E00) Representative electron micrographs of transversely
sectioned embryos at 27 hpf. Erythroid cells in the subaortic
region, in the PCV, and during invasion through the endothe-
lial cell layer are shown. Scale bar represents 10 mm.
(E) Electron micrograph of a transversely sectioned embryo
showing the aorta, the cardinal vein, and the subaortic region
between them. Black boxes indicate areas shown enlarged
in (E0) and (E00).
(E0) Enlargement of (E) showing an invading erythroid cell
(BC, blood cell) firmly surrounded by endothelial cells (EC).
(E00) Enlargement of (E) showing erythroid cell tethered on the
lumen of the PCV. White arrowheads indicate blood-vessel
contact; black arrowheads indicate vessel-vessel contact.
(F) Confocal images of embryos immunostained with anti-
vinculin antibody (cyan) showing vinculin expression at the
interface between erythroid and endothelial cells as well as
among endothelial cells (24 hpf), followed by a gradual
decrease (27 hpf). The vinculin signal disappears at the
blood-vessel interface after the onset of blood circulation
while remaining intracellularly in some erythroid cells
(30 hpf). Scale bars represent 25 mm.
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1111collagen-mimicking hydroxamate that attacks the active sites
of broad-spectrum metalloproteases including matrix metallo-
proteases (MMPs) and a disintegrin and metalloprotease
(ADAM)-family proteases [10, 11]. Transient and local adminis-
tration of such inhibitors was critical in this study because both
MMPs and ADAMs participate in many cellular processes
including blood vessel and endocardial development and
transmigration (extravasation) of lymphocytes in mammals
[12–14]. When defined amounts of metalloprotease inhibitors
were injected into the flow after vessel formation, blood circu-
lation was severely affected in some embryos (Figure 2). Other
embryos showed only partial effects (Movie S3), and there was
no apparent effect on heartbeat (data not shown), fli1a:eGFP-
labeled blood vessel development, or plasma flow monitored
with fluorescent dextran. Furthermore, some erythroid cells
circulated efficiently in spite of significant stagnation of other
erythroid cells, suggesting that the inhibitors had a minimal
effect on flow velocity in these experiments. Detailed analyses
of embryos also revealed that we could minimize possibleinhibitory effects of metalloprotease inhibitors on the invasion
step (Figures S1D–S1G). GM6001-control, a chemical related
to GM6001 but ineffective against metalloproteases, did not
affect blood circulation, suggesting that the observed effects
of GM6001 were specific. These results suggest that intravas-
cular metalloproteases play some role in the release of primi-
tive blood.
ADAM8 Is Essential for the Onset of Blood Circulation
The ADAM-family proteases are candidate promotive factors
for blood detachment from the vessel wall because of their
demonstrated roles in the ectodomain shedding of various
cell adhesion molecules such as E- and N-cadherin, L-selectin,
and P-selectin glycoprotein ligand-1 (PSGL-1) [13, 15].
Because some blood precursors remained attached to ves-
sels after the start of blood circulation in wild-type embryos
(Movie S1), cells to be released into the flow could be preferen-
tially segregated from adherent ones through local proteoly-
sis of adhesion molecules expressed on individual blood
Figure 2. Injection of Metalloprotease Inhibitors into the Flow Disturbs the Onset of Blood Circulation
(A) Protocol for monitoring effects of metalloprotease inhibitors (orthophenanthroline or GM6001) on blood circulation. These reagents were injected into the
flow together with dye-labeled dextran (cyan) at 24 hpf. Blood circulation was observed at 30 hpf.
(B and C) Effects of metalloprotease inhibitors and those of solvents (mock) on the onset of blood circulation were observed under a stereomicroscope.
(B) Effects of metalloprotease inhibitors were evaluated by counting embryos showing complete blood stagnation (black bars) and those with partial stag-
nation (gray bars).
(C) Abnormal accumulation of gata1:mRFP+ cells is indicated by white arrowheads. Note that metalloprotease inhibitor-injected embryos exhibit efficient
flow of dye-labeled dextran (cyan). The effects of these inhibitors are transient, and blood circulation starts within a few hours, suggesting recovery of
proteolytic activity. Scale bars represent 250 mm.
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1112precursors rather than proteolysis initiated by the endothelial
cells. This idea led us to hypothesize specific roles for blood-
derived metalloproteases in the onset of blood circulation,
although we do not exclude the involvement of vascular-
derived metalloproteases in this process. We conducted an
in silico analysis of ADAM proteases expressed in blood. Anal-
ysis of expressed sequence tags (ESTs) from human tissues
revealed that adam8 is preferentially expressed in blood
(Figures S2A and S2B), consistent with its original isolation
from blood [16]. Zebrafish adam8 (NCBI gene ID 368917) is
highly expressed in kidney, the main hematopoietic tissue of
adult fish [3] (Figure S2C). Whole-mount in situ hybridization
further showed adam8 expression in various hematopoietic
locations in embryos: the ICM, macrophages on the yolk
surface, the posterior blood island (PBI; Figures 3A–3C), and
the region equivalent to the aorta-gonad-mesonephros (AGM;
Figure S2I), locations for definitive hematopoiesis [17–21].
adam8 was preferentially expressed in subaortic blood, not
the blood vessels, of the ICM (Figure 3D). ADAM8-mCherry
fusion protein exhibited membrane localization in blood
precursors (Figure 3E).
To examine roles of adam8 in blood development, we
knocked down its expression by injecting antisense morpholi-
nos (MOs) targeting either the translation initiation site (adam8
MO-1) or a splice site (adam8MO-2) (Figures S2J and S2K) into
fertilized embryos. A dramatic failure in blood circulation was
observed in both types of adam8 morphants, whereas control
embryos showed vigorous circulation of erythroid cells by
28–29 hpf (Figures 3F–3J; Movie S4; Movie S5). Detailed anal-
yses revealed defective blood circulation onset in the adam8
morphants despite normal blood vessel formation and inva-
sion of erythroid cells into the blood vessels. The mutant lines
silent heart (mutation in the troponin t2 gene) and gridlockshow abnormal accumulation of blood as a result of heartbeat
failure and defective cell fate determination in blood vessel
precursors, respectively [22, 23]. In contrast to troponin t2
morphants, heartbeat initiated normally in our adam8 mor-
phants (data not shown). gridlock mutants exhibit blood flow
in the anterior region, but not in the trunk or tail region, and
this was attributed to disrupted aortic bifurcation and defec-
tive artery development [24]. In contrast, fli1a:eGFP+ vascula-
ture morphology (Figures 3F and 3H) and expression of kdrl (a
vegf receptor-2 ortholog) (data not shown) indicated grossly
normal vascular formation in adam8 morphants, with delayed
development of intersegmental vessels in some embryos.
Rapid bloodstream flow and local congestion were often
concurrent in adam8 morphants, which also excluded primary
defects in establishing the circulatory organ (Movie S5).
Normal plasma circulation through the major vessels in these
embryos was further verified by the efficient circulation of
dye injected into the flow at 30 hpf, which was in contrast to
the absence of dye flow in troponin t2 morphants (Figure 3F).
The adam8 morphants expressed gata1 and a-e1-globin tran-
scripts but accumulated them abnormally in the trunk (Fig-
ure 3K), suggesting roles for adam8 in blood circulation per
se rather than in development of the cardiovascular system
or cell fate determination of erythroid precursors.
ADAM8 Metalloprotease Activity Is Required Cell
Autonomously in Primitive Blood for the Abrogation
of Blood-Vessel Adhesion
ADAM8 is expressed in the primitive blood rather than in endo-
thelial cells. To determine whether ADAM8 acts as a protease
in erythroid cells, we expressed either wild-type ADAM8 or
a metalloprotease-inactive form (ADAM8 EQ; [25]) under the
control of a gata1 promoter together with GFP [26]. Expression
Figure 3. ADAM8 Is Essential for the Release of Primitive Blood into Circulation
(A–D) ADAM8 is expressed in hematopoietic tissues.
(A and B) The whole-mount in situ hybridization signal for adam8 mRNA is high in the subaortic region (also shown in the enlarged panel in A) of the inter-
mediate cell mass, the posterior blood island (white arrowheads), and macrophages within the yolk (black arrowheads). Scale bars represent 250 mm.
(C) Transverse sections of embryos at 26 hpf indicate coexpression of adam8 and gata1 in clustered blood cells in the subaortic region. Scale bars represent
25 mm.
(D) adam8 mRNA is high in the subaortic region, but not in endothelial cells expressing kdrl. Scale bars represent 25 mm.
(E) Membrane localization of zebrafish ADAM8 (zADAM8) protein. zADAM8-mCherry fusion protein was expressed in blood precursors under the control of
a gata1 promoter. Scale bar represents 5 mm.
(F–I) Depletion of ADAM8 causes blood congestion.
(F and G) Representative images of live Tg(fli1a:eGFP)y1 Tg(gata1:mRFP)ko5 embryos injected with control oligo MO, antisenseadam8MO-1, antisenseadam8
MO-2, or antisense troponin t2 MO observed by stereomicroscopy at 30 hpf (F) or by confocal microscopy at 26–30 hpf (G). In (F), accumulation of gata1:
mRFP+ cells in the trunk is evident both in adam8 and troponin t2 morphants (white arrowheads). Dye-labeled dextran injected into the heart at 29 hpf enters
into the circulation efficiently in the adam8morphants (yellow arrowheads), but not in the troponin t2morphant. In the adam8MO-1 morphant, the intensity of
fluorescent dextran is weak because blood cells that fully occupy the inside of the vessels restrict space for the dye. Scale bars represent 250 mm.
(H) Representative Z stack images of embryos at 30 hpf. Intravascular blood accumulation is apparent in the adam8 morphant. Scale bars represent 25 mm.
(I) Erythroid cells of theadam8morphant invade actively from the subaortic region into the vasculature (marked with colored dots). Scale bar represents 25mm.
(J) The ratio of embryos that initiate blood circulation increases between 27 and 29 hpf in wild-type (black line) and control-oligo-injected (blue line) embryos,
but not in adam8 morphants (red line).
(K) In adam8 morphants, erythrocytes expressing gata1 and a-e1-globin accumulate in the trunk vessels abnormally at 30 hpf. Scale bars represent 250 mm.
(L) Top: the active and inactive (EQ mutant) forms of ADAM8 were expressed under the control of a gata1 promoter together with GFP. Bottom: GFP-positive
erythroid cells stagnate in the vasculature in the presence of inactive ADAM8. Scale bars represent 250 mm.
(M) Representative electron micrographs of transversely sectioned adam8morphants at 27 hpf. Erythroid cells adhere to the endothelial cells in the lumen of
the PCV. Scale bars represent 10 mm (upper panel) and 1 mm (lower panel).
(N) Vinculin is highly expressed at the interface between erythroid cells and endothelial cells and on the surface of erythroid cells in adam8 morphants at
27 hpf. Scale bars represent 25 mm (left) and 5 mm (right).
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Figure 4. Onset of Blood Circulation Is Dependent on Metalloproteases and
on the Flow
(A and B) Mouse ADAM8 (mADAM8), mADAM8 EQ, zADAM8, zADAM8 EQ,
or empty vector cDNA was coexpressed with mPSGL-1-HA (A) or zPSGL-1-
HA (B) in HEK293T cells. Ectodomain shedding was assessed by western
blotting for HA. Signals for long forms (L-L, dimer; L, monomer) were
decreased and those for short forms (S) were increased significantly by
expression of mADAM8 and zADAM8, but not by expression of EQ mutants.
Dimeric forms cannot be found with zPSGL-1, probably because the
N-terminal region missing in zPSGL-1 is required for the dimerization of
mPSGL-1. Asterisks indicate intracellular forms.
(C) A working hypothesis on the onset of primitive blood circulation. As a first
step, erythroid cells adhere to the lumen of the vasculature after intravasa-
tion until the majority of blood cells transmigrate into the vasculature
(‘‘idling’’). Next, these cells are released almost simultaneously through
two conceivable pathways. In the first, ADAM8 activation in response to
a threshold flow velocity or by some stimulus emanating from the vessel
lumen causes detachment of erythroid cells and triggers the synchronous
onset of blood circulation. In the second, ADAM8-dependent abrogation
of erythroid cell adhesion (blue lines) to the blood vessels is a prerequisite,
but not a direct trigger, for the synchronous onset of blood circulation. In
this case, other stimuli would still be needed for release, such as a threshold
flow or the removal of unknown molecules on the vasculature that prevent
the release of blood cells. When the heartbeat starts, regurgitation of the
flow occurs as a result of the heart valve immaturity. Thus, a unidirectional
threshold flow would be generated by maturation of both the heart valve and
the heart muscle. The threshold flow would then facilitate flattening and
smoothing of blood vessel lumens and/or degradation of extracellular
matrix proteins on the vessels that might loosely trap blood cells. Such an
abrupt alteration in the vessel could be a direct trigger for the sudden and
simultaneous onset of primitive blood circulation.
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1114of ADAM8 EQ, but not wild-type ADAM8, caused accumulation
of GFP+ blood cells in the lumen of vessels, suggesting that
ADAM8 EQ has a dominant-negative effect in primitive eryth-
roblasts and inhibits their detachment from the vessels
(Figure 3L). These results not only indicate cell-autonomous
roles of ADAM8 in the blood but also imply a requirement for
ADAM8 metalloprotease activity in the abrogation of blood-
vessel adhesion. Moreover, adam8 morphants exhibited
remarkable adhesion between erythroid cells and the vascula-
ture surface in electron micrographs and strong immunostain-
ing of vinculin on the surface of erythroid cells (Figures 3M and
3N). These results suggest a critical role for ADAM8 in disrupt-
ing blood-vessel adhesion at the onset of blood circulation.
To identify possible substrates of ADAM8 in the hematopoi-
etic system, we searched again for human ESTs encoding cell
adhesion molecules with a tissue distribution similar to that of
adam8. Among those identified, we focused on l-selectin (data
not shown) and psgl-1 (Figure S2A) because these genes
encode proteins that undergo ectodomain shedding [27, 28].
L-selectin was not cleaved significantly by ADAM8 (data not
shown) and so was not pursued further in this study. PSGL-1
is a major mucin-type adhesion protein expressed in mam-
malian blood. Recombinant soluble PSGL-1 accelerates
thrombolysis and prevents occlusion [29], and some viper
venom metalloproteases such as mocarhagin are known to
degrade PSGL-1 [30]. We isolated a cDNA encoding zebrafish
PSGL-1 (zPSGL-1; GenScript gene ID GN945319) and tagged it
hemagglutinin (HA) at the C terminus. Western blotting and
flow cytometry (data not shown) showed that the ectodomain
of mouse PSGL-1 or that of zPSGL-1 was efficiently shed by
both mADAM8 and zADAM8 in HEK293T cells (Figures 4A
and 4B). Thus, ADAM8 is an active metalloprotease that can
shed the ectodomain of cell adhesion molecules such as
PSGL-1.
Functional Significance of ADAM8-Dependent Release
of Blood at the Onset of Blood Circulation
In this study, live imaging enabled us to dissect the onset
of primitive blood circulation into three discrete states of
erythroid cells in zebrafish: (1) invasion through the endothelial
cell layer, (2) ‘‘idling’’ or pausing on the lumen of the vascula-
ture, and (3) release into the circulation almost simultaneously.
This dissection revealed roles of ADAM8 in the progression
from idling to release of blood cells. Detachment of blood cells
from blood vessels at the onset of blood circulation was
primarily affected by both ADAM8 depletion and blood-spe-
cific expression of mutant ADAM8. The potential role of
ADAM8 in disruption of blood-vessel adhesion was supported
by ultrastructural observations and differences in expression
of vinculin at the blood-vessel interface between control and
adam8 morphants. Based on these findings, we propose that
the onset of primitive blood circulation is regulated not only
passively by flow and/or cardiovascular development but
also cell autonomously by ADAM8 in the blood (Figure 4C).
Molecular mechanisms underlying the simultaneous release
of primitive erythroid cells into the circulation remain elusive;
ADAM8 can be a trigger or a prerequisite, but not a direct
trigger. We favor the latter mechanism, based on our findings
that some ‘‘nonadherent-looking’’ cells in the posterior car-
dinal vein also remained idle despite the start of heartbeat until
the simultaneous circulation onset. On the other hand, many
gata1-RFP+ cells in the posterior blood island likely remained
adherent to the blood vessel at the onset of primitive blood
circulation (Figure 3F). These regional differences might reflecta stage-specific activation of ADAM8 in gata1-RFP+ cells, or
among different lineages of gata1-RFP+ cells.
This study did not clarify the molecular basis of the primitive
blood-vessel adhesion or physiological substrates of ADAM8.
ADAM8-Dependent Onset of Blood Circulation
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close homolog of L1) [25], we could not find any orthologs
for CHL1 and L1 in the zebrafish genome. We instead selected
PSGL-1 as a candidate ADAM8 substrate by screening human
ESTs in silico and by ectodomain shedding of PSGL-1 with
ADAM8 in vitro. Developmental arrest was observed in psgl-
1-depleted embryos before 24 hpf, suggesting that psgl-1
itself is required before the stage of blood circulation onset
(Figures S3A and S3B). Thus, we could neither demonstrate
nor exclude a role for PSGL-1 in primitive blood adhesion to
the vessel or as a physiological substrate of ADAM8 at the
onset of blood circulation. Determining the role of ADAM8 in
disrupting focal contacts would help to identify physiological
substrates of ADAM8 in future studies. CD41 (integrin aIIb) is
expressed in primitive and definitive blood in mammals, and
in definitive blood in zebrafish [20], implicating CD41 or related
integrins in the formation of focal contacts in erythroid precur-
sors. PSGL-1 is involved in the weak adhesion on the vascula-
ture, but it activates integrin-mediated firm adhesion in
mammals [31]. In this context, PSGL-1-related glycoproteins
and/or integrin-associated proteins are candidate physiolog-
ical substrates of ADAM8 at the onset of blood circulation.
Why does the onset of primitive blood circulation require
protease-dependent regulation in addition to heartbeat-
dependent passive control? First, proteolysis would segregate
populations of blood cells to be released into the circulation
from those retained on the vasculature. Second, the onset of
blood circulation should be strictly associated with develop-
ment of the circulatory organ to prevent any leakage before
vasculogenesis is complete, or to avoid stagnation before
the plasma flow rate increases. In that context, it is important
to elucidate whether ADAM8 is activated by signaling mole-
cules emanating from the vasculature or by mechanical stress
from the flow. Third, the idling and release might be linked to
the differentiation of erythroid cells, as suggested previously,
whereby differentiation of blood cells requires plasma flow in
both zebrafish and mammals [32, 33]. Another study has
shown the differentiation of primitive erythrocytes occurring
in the bloodstream through the yolk sac in mice [34]. Further
analyses are required to determine whether ADAM8-depen-
dent detachment regulates the differentiation of primitive
erythroid cells.
Similar cell-autonomous, proteolysis-dependent mecha-
nisms for release into circulation might be used by various
blood cell types in vertebrates, such as primitive erythroid
cells in mice, which move from the blood island to embryo
proper in a stepwise pattern, not gradually [35]. Although
ADAM8-deficient mice survive without apparent phenotypes
[36], it remains elusive whether primitive or definitive blood
circulation is affected in these mice.
Supplemental Information
Supplemental Information includes Supplemental Experimental Proce-
dures, three figures, and five movies and can be found with this article online
at doi:10.1016/j.cub.2010.04.052.
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